MarketCap
Facebook
X
TelegramAnnual report 2025
added 03-30-2026
Precipio Operating Cycle 2011-2026 | PRPO
Annual Operating Cycle Precipio
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 43.8 | 39.1 | 49.8 | 67.2 | 58.2 | 78.2 | 90.1 | 115 | 196 | 57.7 | 67.7 | 166 | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 196 | 39.1 | 85.7 |
Quarterly Operating Cycle Precipio
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 45.6 | 46.5 | 41.8 | - | 38 | 40.5 | 46 | - | 44.2 | 45.4 | 58.4 | - | 76.4 | 77.6 | 62.9 | - | 53.4 | 50.2 | 65.2 | - | 74.6 | 89.1 | 76.7 | - | 89 | 77.4 | 107 | - | 124 | 105 | 115 | - | 289 | 308 | 143 | - | 117 | 78.9 | 101 | - | 83.2 | 64.3 | 49.3 | 34.7 | 274 | 166 | 179 | 78 | 159 | 150 | 183 | 101 | 207 | 184 | 199 | 80.6 | 176 | 203 | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 308 | 34.7 | 110 |
Operating Cycle of other stocks in the Diagnostics research industry
| Issuer | Operating Cycle | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Centogene N.V.
CNTG
|
170 | - | -6.23 % | $ 30.6 M |  Germany |
 |
Agilent Technologies
A
|
161 | $ 115.48 | - | $ 35.1 B |  USA |
 |
Aspira Women's Health
AWH
|
1.2 K | - | -6.19 % | $ 10.5 M | USA |
 |
Biocept
BIOC
|
134 | - | -13.05 % | $ 7.29 M | USA |
|
Akumin
AKU
|
57.4 | - | -17.87 % | $ 25.9 M |  Canada |
 |
Accelerate Diagnostics
AXDX
|
489 | - | -61.36 % | $ 2.46 M | USA |
 |
Global Cord Blood Corporation
CO
|
202 | - | - | $ 399 M |  China |
 |
Genetic Technologies Limited
GENE
|
11.8 K | - | - | $ 7.1 B |  Australia |
 |
Genetron Holdings Limited
GTH
|
185 | - | 0.12 % | $ 80.1 M | China |
 |
Exact Sciences Corporation
EXAS
|
91.7 | - | - | $ 19.8 B | USA |
 |
PRA Health Sciences, Inc.
PRAH
|
1.22 K | - | - | $ 10.7 B | USA |
 |
DermTech
DMTK
|
114 | - | -11.32 % | $ 2.94 M | USA |
 |
Enzo Biochem
ENZ
|
206 | - | -8.98 % | $ 14.8 K | USA |
 |
Heska Corporation
HSKA
|
177 | - | - | $ 1.31 B | USA |
 |
HTG Molecular Diagnostics
HTGM
|
216 | - | -20.0 % | $ 1.06 M | USA |
 |
QIAGEN N.V.
QGEN
|
172 | - | - | $ 10.6 B |  Niderland |
 |
Chembio Diagnostics
CEMI
|
164 | - | 0.22 % | $ 16.8 M | USA |
 |
Motus GI Holdings
MOTS
|
3.45 K | - | -34.28 % | $ 263 K |  Israel |
 |
Invitae Corporation
NVTA
|
368 | - | - | $ 21.2 M | USA |
 |
Organovo Holdings
ONVO
|
79.8 | - | -2.3 % | $ 19.4 M | USA |
 |
OpGen
OPGN
|
4.66 | - | -16.95 % | $ 1.54 M | USA |
 |
PerkinElmer
PKI
|
92.2 | - | -0.91 % | $ 14.7 B | USA |
 |
Psychemedics Corporation
PMD
|
61.3 | - | -1.84 % | $ 15.3 M | USA |
 |
Renalytix AI plc
RNLX
|
15.9 | - | 5.66 % | $ 22.7 M |  Britain |
 |
Quotient Limited
QTNT
|
432 | - | -11.32 % | $ 1.1 M |  Schweiz |
 |
Syneos Health
SYNH
|
102 | - | - | $ 4.46 B | USA |
 |
Meridian Bioscience
VIVO
|
238 | - | - | $ 1.49 B | USA |
 |
Surmodics
SRDX
|
201 | - | - | $ 608 M | USA |
 |
Anixa Biosciences
ANIX
|
275 | $ 2.55 | - | $ 82.8 K | USA |
|
Biodesix
BDSX
|
41.7 | $ 15.07 | - | $ 1.95 B | USA |
 |
Biomerica
BMRA
|
204 | $ 2.17 | - | $ 4.98 M | USA |
 |
BioNano Genomics
BNGO
|
315 | $ 1.2 | - | $ 6.53 M | USA |
 |
Burning Rock Biotech Limited
BNR
|
275 | $ 16.2 | - | $ 175 M | China |
 |
T2 Biosystems
TTOO
|
91.3 | - | -39.35 % | $ 313 K | USA |
 |
Bioventus
BVS
|
259 | $ 8.97 | - | $ 598 M | USA |
 |
CareDx, Inc
CDNA
|
51.5 | $ 18.31 | - | $ 976 M | USA |
 |
RadNet
RDNT
|
34.5 | $ 54.79 | - | $ 4.12 B | USA |
 |
Co-Diagnostics
CODX
|
1.79 K | $ 4.4 | 101.83 % | $ 5.85 M | USA |
 |
Charles River Laboratories International
CRL
|
65 | $ 173.89 | 0.07 % | $ 8.62 B | USA |
 |
Castle Biosciences
CSTL
|
97.9 | $ 24.84 | - | $ 690 M | USA |
 |
Quest Diagnostics Incorporated
DGX
|
54.2 | $ 198.02 | 0.44 % | $ 22 B | USA |
 |
Danaher Corporation
DHR
|
143 | $ 191.12 | - | $ 136 B | USA |
 |
DarioHealth Corp.
DRIO
|
227 | $ 8.4 | - | $ 33.5 M | Israel |
 |
DexCom
DXCM
|
202 | $ 62.22 | - | $ 24.3 B | USA |
 |
Fulgent Genetics
FLGT
|
77.4 | $ 16.82 | - | $ 509 M | USA |
 |
Guardant Health
GH
|
128 | $ 93.83 | - | $ 11.8 B | USA |